Behavioural Neurology

Behavioural Neurology / 2004 / Article

Open Access

Volume 15 |Article ID 409248 | https://doi.org/10.1155/2004/409248

Ron Dabby, Nathan Watemberg, Yair Lampl, Anda Eilam, Abraham Rapaport, Menachem Sadeh, "Pathological Laughter as a Symptom of Midbrain Infarction", Behavioural Neurology, vol. 15, Article ID 409248, 4 pages, 2004. https://doi.org/10.1155/2004/409248

Pathological Laughter as a Symptom of Midbrain Infarction

Received24 Jan 2005
Accepted24 Jan 2005

Abstract

Pathological laughter is an uncommon symptom usually caused by bilateral, diffuse cerebral lesions. It has rarely been reported in association with isolated cerebral lesions. Midbrain involvement causing pathological laughter is extremely unusual. We describe three patients who developed pathological laughter after midbrain and pontine-midbrain infarction. In two patients a small infarction in the left paramedian midbrain was detected, whereas the third one sustained a massive bilateral pontine infarction extending to the midbrain. Laughter heralded stroke by one day in one patient and occurred as a delayed phenomenon three months after stroke in another. Pathological laughter ceased within a few days in two patients and was still present at a two year follow-up in the patient with delayed-onset laughter. Pathological laughter can herald midbrain infarction or follow stroke either shortly after onset of symptoms or as a delayed phenomenon. Furthermore, small unilateral midbrain infarctions can cause this rare complication.

Copyright © 2004 Hindawi Publishing Corporation and the authors. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views66
Downloads647
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.